|
Jun 17
|
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
|
|
Jun 16
|
Supernus Pharmaceuticals Snaps Up Beleaguered Sage Therapeutics
|
|
Jun 16
|
Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.
|
|
Jun 16
|
Supernus makes depression drug play with $795m Sage buyout
|
|
Jun 16
|
Sector Update: Health Care Stocks Flat to Higher Premarket Monday
|
|
Jun 16
|
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
|
|
Jun 13
|
3 Small-Cap Stocks Facing Headwinds
|
|
Jun 10
|
1 Cash-Producing Stock for Long-Term Investors and 2 to Keep Off Your Radar
|
|
Jun 6
|
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers
|
|
Mar 14
|
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
|
|
Mar 13
|
3 Small-Cap Stocks Skating on Thin Ice
|
|
Mar 4
|
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
|
|
Mar 4
|
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
|
|
Mar 3
|
Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals?
|
|
Mar 2
|
Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now?
|
|
Feb 27
|
Supernus to Participate in the TD Cowen 45th Annual Health Care Conference
|
|
Feb 24
|
What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings
|
|
Feb 19
|
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
|
|
Feb 18
|
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
|
|
Feb 11
|
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
|